Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 5;4:62-71.
doi: 10.1016/j.toxrep.2016.12.004. eCollection 2017.

Safety Assesment of Bacillus clausii UBBC07, a Spore Forming Probiotic

Affiliations
Free PMC article

Safety Assesment of Bacillus clausii UBBC07, a Spore Forming Probiotic

Suvarna G Lakshmi et al. Toxicol Rep. .
Free PMC article

Abstract

Probiotics are vital bacteria that colonize the intestine and modify its microflora with benefits for the host. Very few members of the Bacillus group are recognized as safe for use and hence only a few strains are available as commercial preparations for application in humans and animals. Acute and subacute studies in rats were conducted to establish safety of Bacillus clausii (B. clausii) UBBC07. In the acute toxicity study, the oral LD50 for B. clausii UBBC07 was found to be >5000 mg/kg (630 billion cfu/kg) body weight. The NOAEL for B. clausii UBBC07 was found to be 1000 (126 billion cfu) mg/kg body weight/day by oral route in the subacute toxicity study. There were no significant differences between control and treated groups in any of the endpoints assessed using an OECD443 or OECD407 protocol. B. clausii UBBC07 was found to be resistant to three antibiotics -clindamycin, erythromycin and chloramphenicol. Analysis of the whole genome sequence of B. clausii UBBC07 revealed that the antibiotic resistance genes are present in chromosomal DNA which is intrinsic and not transferable. Toxin genes were also found to be absent. These results suggest consumption of B. clausii UBBC07 is safe for humans.

Keywords: ALP, alanine amino phosphate; ALT, alanine amino transferase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Acute toxicity; Alb, albumin; B. clausii UBBC07, Bacillus clausii UBBC07; BUN, blood urea nitrogen; Bacillus clausii UBBC07; C, casts; Creat, creatinine; Cry, crystals; EC, epithelial cells; Ery, erythrocytes; GC, granular casts; Glob, globulin; Glu, glucose; Hct, hematocrit; Hgb, hemoglobin; Leu, leucocytes; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; NOAEL; NOAEL, no observed adverse effect level; Pro, protein; RBC, red blood cell; RET, reticulocyte; SG, specific gravity; Subacute toxicity; T.Bil, total bilirubin; T.chol, total cholesterol; TP, total protein; TPC, triple phosphate crystals; Trig, triglycerides; Vol, volume; WBC, white blood cell; Whole genome.

Figures

Fig. 1
Fig. 1
Artemis comparison (erm gene).
Fig. 2
Fig. 2
Artemis comparison (aadD2 gene).
Fig. 3
Fig. 3
Artemis comparison (cat gene).

Similar articles

See all similar articles

Cited by 4 articles

References

    1. Joint F.A.O . Joint, F.A.O.; London, Ontario, Canada: 2002. WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food; p. 30.
    1. Benno Y., Mitsuoka T. Development of intestinal microflora in humans and animals. Bifidobacteria Microflora. 1986;5(1):13–25.
    1. Mazza P. The use of Bacillus subtilis as an antidiarrhoeal microorganism. Boll. Chim. Farm. 1994;133(1):3–18. - PubMed
    1. Barbosa T.M., Serra C.R., La Ragione R.M., Woodward M.J., Henriques A.O. Screening for Bacillus isolates in the broiler gastrointestinal tract. Appl. Environ. Microbiol. 2005;71(2):968–978. - PMC - PubMed
    1. Fuller R. Probiotics in human medicine. Gut. 1991;32(4):439. - PMC - PubMed

LinkOut - more resources

Feedback